Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma
Clinical trial NCT07187960 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07187960
- Sponsor
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2028-10-01
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.